ArticleJournal of experimental & clinical cancer research : CR2026
PARP1-BCAT2 axis upregulates ABCG1 via histone lactylation to drive acquired PARP inhibitor resistance in prostate cancer.
Wangli Mei et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.